LGD-4033 (Ligandrol) 5mg – Zionova
LGD-4033 (Ligandrol) 5mg Zionova United Kingdom Overview
Product Overview
LGD-4033, commonly known as Ligandrol, is a selective androgen receptor modulator (SARM) that is widely discussed in research and fitness-related communities across the United Kingdom. In cities such as London, Manchester, Birmingham, Leeds, and Liverpool, it is often referenced in conversations around muscle preservation and body recomposition research.
This formulation contains 5mg per tablet and is manufactured under Zionova Pharmaceuticals standards. It is typically presented in oral tablet form and is associated in scientific discussions with selective androgen receptor activity in muscle and bone tissue.
Across Glasgow, Bristol, Sheffield, Nottingham, and Newcastle, LGD-4033 is frequently mentioned in research-focused discussions involving lean mass and performance studies.
Key Features
LGD-4033 (Ligandrol) 5mg per tablet
Oral SARM compound
Zionova Pharmaceuticals manufacturing standards
Selective androgen receptor modulator class
Commonly referenced in muscle and bone research discussions
Tablet-based formulation
How It Works
LGD-4033 is a selective androgen receptor modulator that binds to androgen receptors primarily in muscle and bone tissue. This selective activity is studied in research contexts for its potential relationship with lean tissue maintenance and strength-related outcomes.
In discussions across Edinburgh, Cardiff, and Birmingham, it is often referenced in scientific and experimental contexts involving anabolic receptor pathways and tissue response mechanisms.
As a research compound, its long-term effects in humans are not fully established, and it remains under ongoing scientific investigation.
Storage Instructions
Store in a cool, dry place away from heat, moisture, and direct sunlight. Keep securely closed and out of reach of children.




Reviews
There are no reviews yet.